| 000 | 01475 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250515182225.0 | ||
| 264 | 0 | _c20100120 | |
| 008 | 201001s 0 0 eng d | ||
| 022 | _a1473-1150 | ||
| 024 | 7 |
_a10.1038/tpj.2009.36 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aVisscher, H | |
| 245 | 0 | 0 |
_aApplication of principal component analysis to pharmacogenomic studies in Canada. _h[electronic resource] |
| 260 |
_bThe pharmacogenomics journal _cDec 2009 |
||
| 300 |
_a362-72 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAsian People _xgenetics |
| 650 | 0 | 4 |
_aBiotransformation _xgenetics |
| 650 | 0 | 4 |
_aBlack People _xgenetics |
| 650 | 0 | 4 | _aCanada |
| 650 | 0 | 4 | _aDrug-Related Side Effects and Adverse Reactions |
| 650 | 0 | 4 |
_aEthnicity _xgenetics |
| 650 | 0 | 4 | _aGene Frequency |
| 650 | 0 | 4 | _aGenetics, Population |
| 650 | 0 | 4 | _aGenome-Wide Association Study |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aPharmacogenetics _xmethods |
| 650 | 0 | 4 | _aPolymorphism, Single Nucleotide |
| 650 | 0 | 4 | _aPrincipal Component Analysis |
| 650 | 0 | 4 |
_aWhite People _xgenetics |
| 700 | 1 | _aRoss, C J D | |
| 700 | 1 | _aDubé, M-P | |
| 700 | 1 | _aBrown, A M K | |
| 700 | 1 | _aPhillips, M S | |
| 700 | 1 | _aCarleton, B C | |
| 700 | 1 | _aHayden, M R | |
| 773 | 0 |
_tThe pharmacogenomics journal _gvol. 9 _gno. 6 _gp. 362-72 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/tpj.2009.36 _zAvailable from publisher's website |
| 999 |
_c19059715 _d19059715 |
||